KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ionis Pharmaceuticals (IONS) Goodwill & Intangibles: 2009-2022

Historic Goodwill & Intangibles for Ionis Pharmaceuticals (IONS) over the last 13 years, with Sep 2022 value amounting to $29.6 million.

  • Ionis Pharmaceuticals' Goodwill & Intangibles fell 1.44% to $29.6 million in Q3 2022 from the same period last year, while for Sep 2022 it was $29.6 million, marking a year-over-year decrease of 1.44%. This contributed to the annual value of $29.0 million for FY2021, which is 3.82% up from last year.
  • Per Ionis Pharmaceuticals' latest filing, its Goodwill & Intangibles stood at $29.6 million for Q3 2022, which was up 1.90% from $29.1 million recorded in Q2 2022.
  • Ionis Pharmaceuticals' 5-year Goodwill & Intangibles high stood at $30.0 million for Q3 2021, and its period low was $22.9 million during Q1 2018.
  • Its 3-year average for Goodwill & Intangibles is $28.7 million, with a median of $29.0 million in 2021.
  • In the last 5 years, Ionis Pharmaceuticals' Goodwill & Intangibles rose by 12.31% in 2019 and then decreased by 1.44% in 2022.
  • Over the past 5 years, Ionis Pharmaceuticals' Goodwill & Intangibles (Quarterly) stood at $24.0 million in 2018, then increased by 6.83% to $25.7 million in 2019, then climbed by 8.81% to $27.9 million in 2020, then climbed by 3.82% to $29.0 million in 2021, then declined by 1.44% to $29.6 million in 2022.
  • Its Goodwill & Intangibles stands at $29.6 million for Q3 2022, versus $29.1 million for Q2 2022 and $29.3 million for Q1 2022.